Global DDA Quantitative Proteomics Market Research Report 2024

Publication ID:

PB512240104

Publication Date:

December 27, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for DDA Quantitative Proteomics was valued at US$ 6593 million in the year 2023 and is projected to reach a revised size of US$ 12380 million by 2030, growing at a CAGR of 10.7% during the forecast period.
DDA Quantitative Proteomics refers to a research method that uses data-dependent acquisition (DDA) technology combined with mass spectrometry to quantitatively analyze the abundance of proteins. Through this method, researchers can not only identify proteins in samples, but also measure their relative or absolute abundance, thereby helping to understand the dynamic changes and functions of proteins in biological systems.
North American market for DDA Quantitative Proteomics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for DDA Quantitative Proteomics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for DDA Quantitative Proteomics in Medical Research is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of DDA Quantitative Proteomics include Creative Proteomics, MtoZ Biolabs, BGI, MS Bioworks, Creative Biolabs, Crown Bioscience, Evotec, Agilent, Cell Signaling Technology, Applied Biomics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for DDA Quantitative Proteomics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DDA Quantitative Proteomics.
The DDA Quantitative Proteomics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global DDA Quantitative Proteomics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DDA Quantitative Proteomics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Creative Proteomics
MtoZ Biolabs
BGI
MS Bioworks
Creative Biolabs
Crown Bioscience
Evotec
Agilent
Cell Signaling Technology
Applied Biomics
Psomagen
Metware Biotechnology Inc.
Biogenity
VProteomics
Cogentech
Segment by Type
Targeted
Full-spectrum
Segment by Application
Medical Research
Animal Research
Plant Research
Microbiology
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of DDA Quantitative Proteomics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global DDA Quantitative Proteomics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Targeted
1.2.3 Full-spectrum
1.3 Market by Application
1.3.1 Global DDA Quantitative Proteomics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Medical Research
1.3.3 Animal Research
1.3.4 Plant Research
1.3.5 Microbiology
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global DDA Quantitative Proteomics Market Perspective (2019-2030)
2.2 Global DDA Quantitative Proteomics Growth Trends by Region
2.2.1 Global DDA Quantitative Proteomics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 DDA Quantitative Proteomics Historic Market Size by Region (2019-2024)
2.2.3 DDA Quantitative Proteomics Forecasted Market Size by Region (2025-2030)
2.3 DDA Quantitative Proteomics Market Dynamics
2.3.1 DDA Quantitative Proteomics Industry Trends
2.3.2 DDA Quantitative Proteomics Market Drivers
2.3.3 DDA Quantitative Proteomics Market Challenges
2.3.4 DDA Quantitative Proteomics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top DDA Quantitative Proteomics Players by Revenue
3.1.1 Global Top DDA Quantitative Proteomics Players by Revenue (2019-2024)
3.1.2 Global DDA Quantitative Proteomics Revenue Market Share by Players (2019-2024)
3.2 Global DDA Quantitative Proteomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by DDA Quantitative Proteomics Revenue
3.4 Global DDA Quantitative Proteomics Market Concentration Ratio
3.4.1 Global DDA Quantitative Proteomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by DDA Quantitative Proteomics Revenue in 2023
3.5 Global Key Players of DDA Quantitative Proteomics Head office and Area Served
3.6 Global Key Players of DDA Quantitative Proteomics, Product and Application
3.7 Global Key Players of DDA Quantitative Proteomics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 DDA Quantitative Proteomics Breakdown Data by Type
4.1 Global DDA Quantitative Proteomics Historic Market Size by Type (2019-2024)
4.2 Global DDA Quantitative Proteomics Forecasted Market Size by Type (2025-2030)
5 DDA Quantitative Proteomics Breakdown Data by Application
5.1 Global DDA Quantitative Proteomics Historic Market Size by Application (2019-2024)
5.2 Global DDA Quantitative Proteomics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America DDA Quantitative Proteomics Market Size (2019-2030)
6.2 North America DDA Quantitative Proteomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America DDA Quantitative Proteomics Market Size by Country (2019-2024)
6.4 North America DDA Quantitative Proteomics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe DDA Quantitative Proteomics Market Size (2019-2030)
7.2 Europe DDA Quantitative Proteomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe DDA Quantitative Proteomics Market Size by Country (2019-2024)
7.4 Europe DDA Quantitative Proteomics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific DDA Quantitative Proteomics Market Size (2019-2030)
8.2 Asia-Pacific DDA Quantitative Proteomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific DDA Quantitative Proteomics Market Size by Region (2019-2024)
8.4 Asia-Pacific DDA Quantitative Proteomics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America DDA Quantitative Proteomics Market Size (2019-2030)
9.2 Latin America DDA Quantitative Proteomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America DDA Quantitative Proteomics Market Size by Country (2019-2024)
9.4 Latin America DDA Quantitative Proteomics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa DDA Quantitative Proteomics Market Size (2019-2030)
10.2 Middle East & Africa DDA Quantitative Proteomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa DDA Quantitative Proteomics Market Size by Country (2019-2024)
10.4 Middle East & Africa DDA Quantitative Proteomics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Creative Proteomics
11.1.1 Creative Proteomics Company Details
11.1.2 Creative Proteomics Business Overview
11.1.3 Creative Proteomics DDA Quantitative Proteomics Introduction
11.1.4 Creative Proteomics Revenue in DDA Quantitative Proteomics Business (2019-2024)
11.1.5 Creative Proteomics Recent Development
11.2 MtoZ Biolabs
11.2.1 MtoZ Biolabs Company Details
11.2.2 MtoZ Biolabs Business Overview
11.2.3 MtoZ Biolabs DDA Quantitative Proteomics Introduction
11.2.4 MtoZ Biolabs Revenue in DDA Quantitative Proteomics Business (2019-2024)
11.2.5 MtoZ Biolabs Recent Development
11.3 BGI
11.3.1 BGI Company Details
11.3.2 BGI Business Overview
11.3.3 BGI DDA Quantitative Proteomics Introduction
11.3.4 BGI Revenue in DDA Quantitative Proteomics Business (2019-2024)
11.3.5 BGI Recent Development
11.4 MS Bioworks
11.4.1 MS Bioworks Company Details
11.4.2 MS Bioworks Business Overview
11.4.3 MS Bioworks DDA Quantitative Proteomics Introduction
11.4.4 MS Bioworks Revenue in DDA Quantitative Proteomics Business (2019-2024)
11.4.5 MS Bioworks Recent Development
11.5 Creative Biolabs
11.5.1 Creative Biolabs Company Details
11.5.2 Creative Biolabs Business Overview
11.5.3 Creative Biolabs DDA Quantitative Proteomics Introduction
11.5.4 Creative Biolabs Revenue in DDA Quantitative Proteomics Business (2019-2024)
11.5.5 Creative Biolabs Recent Development
11.6 Crown Bioscience
11.6.1 Crown Bioscience Company Details
11.6.2 Crown Bioscience Business Overview
11.6.3 Crown Bioscience DDA Quantitative Proteomics Introduction
11.6.4 Crown Bioscience Revenue in DDA Quantitative Proteomics Business (2019-2024)
11.6.5 Crown Bioscience Recent Development
11.7 Evotec
11.7.1 Evotec Company Details
11.7.2 Evotec Business Overview
11.7.3 Evotec DDA Quantitative Proteomics Introduction
11.7.4 Evotec Revenue in DDA Quantitative Proteomics Business (2019-2024)
11.7.5 Evotec Recent Development
11.8 Agilent
11.8.1 Agilent Company Details
11.8.2 Agilent Business Overview
11.8.3 Agilent DDA Quantitative Proteomics Introduction
11.8.4 Agilent Revenue in DDA Quantitative Proteomics Business (2019-2024)
11.8.5 Agilent Recent Development
11.9 Cell Signaling Technology
11.9.1 Cell Signaling Technology Company Details
11.9.2 Cell Signaling Technology Business Overview
11.9.3 Cell Signaling Technology DDA Quantitative Proteomics Introduction
11.9.4 Cell Signaling Technology Revenue in DDA Quantitative Proteomics Business (2019-2024)
11.9.5 Cell Signaling Technology Recent Development
11.10 Applied Biomics
11.10.1 Applied Biomics Company Details
11.10.2 Applied Biomics Business Overview
11.10.3 Applied Biomics DDA Quantitative Proteomics Introduction
11.10.4 Applied Biomics Revenue in DDA Quantitative Proteomics Business (2019-2024)
11.10.5 Applied Biomics Recent Development
11.11 Psomagen
11.11.1 Psomagen Company Details
11.11.2 Psomagen Business Overview
11.11.3 Psomagen DDA Quantitative Proteomics Introduction
11.11.4 Psomagen Revenue in DDA Quantitative Proteomics Business (2019-2024)
11.11.5 Psomagen Recent Development
11.12 Metware Biotechnology Inc.
11.12.1 Metware Biotechnology Inc. Company Details
11.12.2 Metware Biotechnology Inc. Business Overview
11.12.3 Metware Biotechnology Inc. DDA Quantitative Proteomics Introduction
11.12.4 Metware Biotechnology Inc. Revenue in DDA Quantitative Proteomics Business (2019-2024)
11.12.5 Metware Biotechnology Inc. Recent Development
11.13 Biogenity
11.13.1 Biogenity Company Details
11.13.2 Biogenity Business Overview
11.13.3 Biogenity DDA Quantitative Proteomics Introduction
11.13.4 Biogenity Revenue in DDA Quantitative Proteomics Business (2019-2024)
11.13.5 Biogenity Recent Development
11.14 VProteomics
11.14.1 VProteomics Company Details
11.14.2 VProteomics Business Overview
11.14.3 VProteomics DDA Quantitative Proteomics Introduction
11.14.4 VProteomics Revenue in DDA Quantitative Proteomics Business (2019-2024)
11.14.5 VProteomics Recent Development
11.15 Cogentech
11.15.1 Cogentech Company Details
11.15.2 Cogentech Business Overview
11.15.3 Cogentech DDA Quantitative Proteomics Introduction
11.15.4 Cogentech Revenue in DDA Quantitative Proteomics Business (2019-2024)
11.15.5 Cogentech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Creative Proteomics
MtoZ Biolabs
BGI
MS Bioworks
Creative Biolabs
Crown Bioscience
Evotec
Agilent
Cell Signaling Technology
Applied Biomics
Psomagen
Metware Biotechnology Inc.
Biogenity
VProteomics
Cogentech

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂